Alibaba Health Information Technology (241N) Stock Forecast & Price Target
241N Analyst Ratings
Strong Buy
3Buy1Hold0Sell
Based on 4 analysts giving stock ratings to Alibaba Health Information Technology in the past 3 months
241N Stock 12 Month Forecast
Average Price Target
MXN 10.02▼(-82.99% Downside)Based on 4 Wall Street analysts offering 12 month price targets for Alibaba Health Information Technology in the last 3 months. The average price target is MXN 10.02 with a high forecast of MXN 10.71 and a low forecast of MXN 8.57. The average price target represents a -82.99% change from the last price of MXN 58.93.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 10.71
AverageMXN 10.02
LowMXN 8.57
Highest Price TargetHighestMXN 10.71Average Price TargetMXN 10.02Lowest Price TargetLowestMXN 8.57
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
 Hongda ZhongNot Ranked | Jefferies | MXN 10.71 | buy | -81.82%Downside | Reiterated | 09/30/26 | ||
| Lincoln Kong | Goldman Sachs | MXN 10.00→MXN 8.57 | hold | -85.46%Downside | Reiterated | 09/22/26 | ||
| Unknown AnalystNot Ranked | Huatai Securities | MXN 10.09 | buy | -82.87%Downside | Reiterated | 09/22/26 | ||
| Unknown AnalystNot Ranked | CICC | MXN 10.71 | buy | -81.82%Downside | Reiterated | 09/21/26 | ||
| Alexis Yan | Morgan Stanley | MXN 10.00 | sell | -83.03%Downside | Reiterated | 05/15/26 | ||
| Unknown AnalystNot Ranked | UOB Kay Hian | MXN 14.28 | buy | -75.76%Downside | Reiterated | 04/14/26 | ||
| Unknown AnalystNot Ranked | Bank of America Securities | MXN 14.28 | buy | -75.76%Downside | Reiterated | 04/14/26 | ||
| Unknown AnalystNot Ranked | GF Securities | MXN 17.59→MXN 14.97 | buy | -74.59%Downside | Reiterated | 04/09/26 | ||
| Unknown AnalystNot Ranked | CLSA | MXN 12.62 | buy | -78.59%Downside | Reiterated | 04/08/26 | ||
| Unknown AnalystNot Ranked | UBS | MXN 9.76 | sell | -83.44%Downside | Reiterated | 04/07/26 | ||
| Unknown AnalystNot Ranked | HSBC | MXN 15.47 | hold | -73.74%Downside | Reiterated | 02/09/26 | ||
| Unknown AnalystNot Ranked | Citi | MXN 21.42 | buy | -63.64%Downside | Reiterated | 02/05/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | MXN 28.80 | buy | -51.12%Downside | Reiterated | 01/15/26 | ||
| Unknown AnalystNot Ranked | Guotai Haitong | MXN 13.54 | buy | -77.02%Downside | Reiterated | 12/03/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Hongda ZhongNot Ranked | 09/30/26 | MXN 10.71 | buy | -81.82%Downside | Reiterated | Jefferies | ||
| Lincoln Kong | 09/22/26 | MXN 10.00→MXN 8.57 | hold | -85.46%Downside | Reiterated | Goldman Sachs | ||
| Unknown AnalystNot Ranked | 09/22/26 | MXN 10.09 | buy | -82.87%Downside | Reiterated | Huatai Securities | ||
| Unknown AnalystNot Ranked | 09/21/26 | MXN 10.71 | buy | -81.82%Downside | Reiterated | CICC | ||
| Alexis Yan | 05/15/26 | MXN 10.00 | sell | -83.03%Downside | Reiterated | Morgan Stanley | ||
| Unknown AnalystNot Ranked | 04/14/26 | MXN 14.28 | buy | -75.76%Downside | Reiterated | UOB Kay Hian | ||
| Unknown AnalystNot Ranked | 04/14/26 | MXN 14.28 | buy | -75.76%Downside | Reiterated | Bank of America Securities | ||
| Unknown AnalystNot Ranked | 04/09/26 | MXN 17.59→MXN 14.97 | buy | -74.59%Downside | Reiterated | GF Securities | ||
| Unknown AnalystNot Ranked | 04/08/26 | MXN 12.62 | buy | -78.59%Downside | Reiterated | CLSA | ||
| Unknown AnalystNot Ranked | 04/07/26 | MXN 9.76 | sell | -83.44%Downside | Reiterated | UBS | ||
| Unknown AnalystNot Ranked | 02/09/26 | MXN 15.47 | hold | -73.74%Downside | Reiterated | HSBC | ||
| Unknown AnalystNot Ranked | 02/05/26 | MXN 21.42 | buy | -63.64%Downside | Reiterated | Citi | ||
| Unknown AnalystNot Ranked | 01/15/26 | MXN 28.80 | buy | -51.12%Downside | Reiterated | Citic Securities | ||
| Unknown AnalystNot Ranked | 12/03/25 | MXN 13.54 | buy | -77.02%Downside | Reiterated | Guotai Haitong |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Alibaba Health Information Technology
3 Months
Success Rate3/3 ratings generated profit
100%
Average Return
+9.37%
Copying Alexis Yan's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +9.37% per trade.
1 Year
Success Rate3/3 ratings generated profit
100%
Average Return
+36.20%
Copying Alexis Yan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +36.20% per trade.
2 Years
Success Rate3/3 ratings generated profit
100%
Average Return
+36.20%
Copying Alexis Yan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +36.20% per trade.
241N Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 2 | 2 |
| Buy | 7 | 2 | 0 | 1 | 1 |
| Hold | 2 | 1 | 0 | 1 | 1 |
| Sell | 2 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 12 | 5 | 0 | 4 | 4 |
In the current month, 241N has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 241N average Analyst price target in the past 3 months is 10.02.
241N Financial Forecast
HighMXN 0.20
ConsensusMXN 0.20
LowMXN 0.20
241N Earnings Forecast
Next quarter’s earnings estimate for 241N is MXN 0.20 with a range of MXN 0.20 to MXN 0.20. The previous quarter’s EPS was MXN 0.17. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 51.1B
ConsensusMXN 50.8B
LowMXN 50.4B
241N Sales Forecast
Next quarter’s sales forecast for 241N is MXN 50.76B with a range of MXN 50.39B to MXN 51.06B. The previous quarter’s sales results were MXN 46.78B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
241N Stock Forecast FAQ
What is MX:241N’s average 12-month price target, according to analysts?
Based on analyst ratings, Alibaba Health Information Technology’s 12-month average price target is Mex$10.02.
What is MX:241N’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MX:241N, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Alibaba Health Information Technology a Buy, Sell or Hold?
Alibaba Health Information Technology has a consensus rating of Strong Buy, which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Alibaba Health Information Technology’s share price target?
The average share price target for Alibaba Health Information Technology is Mex$10.02. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$10.71, and the lowest forecast is Mex$8.57. The average share price target represents a 82.99% decrease from the current price of Mex$58.93.
What do analysts say about Alibaba Health Information Technology?
Alibaba Health Information Technology’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Alibaba Health Information Technology?
To buy shares of MX:241N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
